The Ocular Surface Center team uses high-resolution, non-invasive optical coherent tomography. This state-of-the-art technology allows them to obtain microscopic imaging of the ocular surface. That way, they see changes that cannot be seen by standard equipment. The team is also establishing a unique biological diagnostic program that utilizes biochemical, genetic, molecular, and immunological analysis of tear fluid and cellular tissue. Their findings help them to better characterize patients by disease process, develop new biomarkers that will help them monitor progression of disease, and provide customized therapy for each individual patient.